HEALTH ITALIA SPA (HI.MI) Fundamental Analysis & Valuation

BIT:HI • IT0005585861

299 EUR
+1 (+0.34%)
Last: Mar 2, 2026, 07:00 PM

This HI.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

HI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 30 industry peers in the Health Care Providers & Services industry. HI gets an excellent profitability rating and is at the same time showing great financial health properties. HI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. HI.MI Profitability Analysis

1.1 Basic Checks

  • In the past year HI was profitable.
  • HI had a positive operating cash flow in the past year.
  • Each year in the past 5 years HI has been profitable.
  • Each year in the past 5 years HI had a positive operating cash flow.
HI.MI Yearly Net Income VS EBIT VS OCF VS FCFHI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

  • HI has a Return On Assets of 6.33%. This is amongst the best in the industry. HI outperforms 87.50% of its industry peers.
  • Looking at the Return On Equity, with a value of 12.31%, HI is in the better half of the industry, outperforming 71.88% of the companies in the same industry.
  • HI's Return On Invested Capital of 7.54% is fine compared to the rest of the industry. HI outperforms 75.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for HI is in line with the industry average of 6.83%.
  • The 3 year average ROIC (7.13%) for HI is below the current ROIC(7.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.33%
ROE 12.31%
ROIC 7.54%
ROA(3y)3.96%
ROA(5y)3.25%
ROE(3y)7.81%
ROE(5y)6.83%
ROIC(3y)7.13%
ROIC(5y)6%
HI.MI Yearly ROA, ROE, ROICHI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • HI's Profit Margin of 8.64% is amongst the best of the industry. HI outperforms 90.63% of its industry peers.
  • HI's Profit Margin has improved in the last couple of years.
  • HI has a Operating Margin of 13.27%. This is amongst the best in the industry. HI outperforms 90.63% of its industry peers.
  • HI's Operating Margin has improved in the last couple of years.
  • The Gross Margin of HI (29.23%) is better than 62.50% of its industry peers.
  • In the last couple of years the Gross Margin of HI has remained more or less at the same level.
Industry RankSector Rank
OM 13.27%
PM (TTM) 8.64%
GM 29.23%
OM growth 3Y8%
OM growth 5YN/A
PM growth 3Y33.22%
PM growth 5Y9.47%
GM growth 3Y-1.7%
GM growth 5Y-0.8%
HI.MI Yearly Profit, Operating, Gross MarginsHI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

7

2. HI.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HI is creating some value.
  • The number of shares outstanding for HI has been increased compared to 1 year ago.
  • Compared to 5 years ago, HI has less shares outstanding
  • The debt/assets ratio for HI has been reduced compared to a year ago.
HI.MI Yearly Shares OutstandingHI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
HI.MI Yearly Total Debt VS Total AssetsHI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 3.15 indicates that HI is not in any danger for bankruptcy at the moment.
  • HI's Altman-Z score of 3.15 is amongst the best of the industry. HI outperforms 84.38% of its industry peers.
  • A Debt/Equity ratio of 0.30 indicates that HI is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.30, HI belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 3.15
ROIC/WACC1.02
WACC7.36%
HI.MI Yearly LT Debt VS Equity VS FCFHI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 2.47 indicates that HI has no problem at all paying its short term obligations.
  • HI has a Current ratio of 2.47. This is amongst the best in the industry. HI outperforms 96.88% of its industry peers.
  • A Quick Ratio of 2.47 indicates that HI has no problem at all paying its short term obligations.
  • HI has a better Quick ratio (2.47) than 96.88% of its industry peers.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 2.47
HI.MI Yearly Current Assets VS Current LiabilitesHI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

3

3. HI.MI Growth Analysis

3.1 Past

  • HI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.67%, which is quite impressive.
  • Measured over the past years, HI shows a very strong growth in Earnings Per Share. The EPS has been growing by 181.50% on average per year.
  • The Revenue has decreased by -4.22% in the past year.
  • The Revenue has been growing slightly by 2.37% on average over the past years.
EPS 1Y (TTM)81.67%
EPS 3Y27.76%
EPS 5Y181.5%
EPS Q2Q%27.61%
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y-3.68%
Revenue growth 5Y2.37%
Sales Q2Q%1.23%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HI.MI Yearly Revenue VS EstimatesHI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
HI.MI Yearly EPS VS EstimatesHI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 5 10 15 20

2

4. HI.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.45, HI is valued on the expensive side.
  • The rest of the industry has a similar Price/Earnings ratio as HI.
  • HI is valuated rather cheaply when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.45
Fwd PE N/A
HI.MI Price Earnings VS Forward Price EarningsHI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • HI's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.83
HI.MI Per share dataHI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

  • HI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2YN/A
EPS Next 3YN/A

0

5. HI.MI Dividend Analysis

5.1 Amount

  • HI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

HI.MI Fundamentals: All Metrics, Ratios and Statistics

HEALTH ITALIA SPA

BIT:HI (3/2/2026, 7:00:00 PM)

299

+1 (+0.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap56.81M
Revenue(TTM)35.60M
Net Income(TTM)3.08M
Analysts84.44
Price Target372.3 (24.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.45
Fwd PE N/A
P/S 1.6
P/FCF N/A
P/OCF 44.92
P/B 2.27
P/tB 2.67
EV/EBITDA 9.83
EPS(TTM)16.21
EY5.42%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-7.46
FCFYN/A
OCF(TTM)6.66
OCFY2.23%
SpS187.37
BVpS131.59
TBVpS112.11
PEG (NY)N/A
PEG (5Y)0.1
Graham Number219.08
Profitability
Industry RankSector Rank
ROA 6.33%
ROE 12.31%
ROCE 13.76%
ROIC 7.54%
ROICexc 8.33%
ROICexgc 9.39%
OM 13.27%
PM (TTM) 8.64%
GM 29.23%
FCFM N/A
ROA(3y)3.96%
ROA(5y)3.25%
ROE(3y)7.81%
ROE(5y)6.83%
ROIC(3y)7.13%
ROIC(5y)6%
ROICexc(3y)7.88%
ROICexc(5y)6.76%
ROICexgc(3y)8.74%
ROICexgc(5y)7.6%
ROCE(3y)12.74%
ROCE(5y)10.6%
ROICexgc growth 3Y-3.65%
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.37%
ROICexc growth 5YN/A
OM growth 3Y8%
OM growth 5YN/A
PM growth 3Y33.22%
PM growth 5Y9.47%
GM growth 3Y-1.7%
GM growth 5Y-0.8%
F-Score4
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 1.28
Cap/Depr 242.82%
Cap/Sales 7.54%
Interest Coverage 250
Cash Conversion 21.7%
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 2.47
Altman-Z 3.15
F-Score4
WACC7.36%
ROIC/WACC1.02
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.67%
EPS 3Y27.76%
EPS 5Y181.5%
EPS Q2Q%27.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y-3.68%
Revenue growth 5Y2.37%
Sales Q2Q%1.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-16.56%
EBIT growth 3Y4.03%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-145.27%
FCF growth 3YN/A
FCF growth 5Y-21.09%
OCF growth 1Y-61.44%
OCF growth 3Y55.79%
OCF growth 5Y-20.58%

HEALTH ITALIA SPA / HI.MI FAQ

What is the ChartMill fundamental rating of HEALTH ITALIA SPA (HI.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to HI.MI.


What is the valuation status of HEALTH ITALIA SPA (HI.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to HEALTH ITALIA SPA (HI.MI). This can be considered as Overvalued.


How profitable is HEALTH ITALIA SPA (HI.MI) stock?

HEALTH ITALIA SPA (HI.MI) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for HI stock?

The Price/Earnings (PE) ratio for HEALTH ITALIA SPA (HI.MI) is 18.45 and the Price/Book (PB) ratio is 2.27.


Can you provide the dividend sustainability for HI stock?

The dividend rating of HEALTH ITALIA SPA (HI.MI) is 0 / 10 and the dividend payout ratio is 0%.